Medtech fundings for February 2017 stand at $500.4 million, led by the $75 million credit facility secured by BioDelivery Sciences, the $45 million private placement by Corindus Vascular Robotics, the $41 million funding of Rhythm, Inc., the $37.2 million funding of Entellus Medical, and the $33 million funding of startup Surrozen.
Below are the top fundings for the month. For a complete list of fundings, see link.
Source: Compiled by MedMarket Diligence, LLC
For a historical listing of fundings in medtech, see link.
Financings at medical technology companies for July to date stand at $373.7 million. Companies included are those in MedMarket Diligence’s area of focus: medical device and complementary or directly competing companies.
Below are the individual companies included, ranked by the amount financed at each.
Company (technology focus)
Small Bone Innovations, Inc., raises record $108 million in Series D financing (technologies and treatments for small bones and joints)
ConforMIS Inc. has raised $50 million (custom knee implants and instrumentation)
Oraya Therapeutics has raised $42 million in Series C financing (radiosurgical treatments for eye diseases)
Paradigm Spine has closed on $21.5 million in debt and equity financing (non-fusion spinal implants)
Symetis SA raises $21.2 million to fund clinical trials (percutaneous valve replacement system)
Relievant Medsystems Announces Completion of $20 Million Financing (nerve ablation for treatment of low back pain)
Novasys Medical has received $18.95 million in the second tranche of its fourth round of funding (treatment of stress urinary incontinence)
Lumenis Ltd has received a $15 million equity financing (RF and light-based ablation devices)
BeneChill has raised $13.5 million in Series C funding (therapeutic hypothermia device for cardiac arrest, stroke, and head injury)
Cardiorobotics has raised $11.6 million in an undisclosed financing round (remotely operated minimally invasive probe used in heart and other surgery)
NICO Corp. has raised $10 million in a Series C financing round (minimally invasive removal of tumors from brain and central nervous system tissue)
Chase Medical, Inc., has received $8.1 million of a planned $9.1 million financing round (device used during treatment of congestive heart failure)
Vidacare Corp. has raised $7.6 million in a Series D1 financing round (intraosseous drug and fluid delivery)
EndoGastric Solutions has raised $7.5 million (endoscopic treatment of gastroesophageal reflux and obesity)
Augmenix, Inc., has raised $4.7 million out of a potential $7.5 million undisclosed equity financing round (hydrogel spacers for use in radiation oncology)
SpineGuard S.A. raises $4 million, completing a $15 million first round funding that began with an $11 million round in April (pedicle screw replacement in spine surgery)
SafeStitch Medical, Inc., has entered into two stock purchase agreements with private investors worth $9 million (endoscopic surgical devices)
NeoChord, Inc., has raised $2.8 million in a Series A financing (device for repair of mitral valve regurgitation)
TransMedics, Inc., has raised $2.5 million in a debt offering (organ transplant support technologies)
TriVirix International has raised $750K out of a planned $1.4 million Series C round (contract device manufacturer)